NBLY — Neighbourly Pharmacy Share Price
0.000.00%
Last trade - 00:00- CA$839.05m
- CA$1.17bn
- CA$749.15m
- 66
- 56
- 68
- 68
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 25.9 | ||
| PEG Ratio (f) | 1.02 | ||
| EPS Growth (f) | 34.25% | ||
| Dividend Yield (f) | 0.97% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.43 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 11.02 | ||
| Price to Sales | 0.96 | ||
| EV to EBITDA | 16.34 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.21% | ||
| Return on Equity | -5.41% | ||
| Operating Margin | 0.23% | ||
Financial Summary
| Year End 25th Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 150.13 | 186.63 | 306.49 | 427.51 | 749.15 | 900.25 | 1,018.4 | 51.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +30.91 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.
Directors
- Last Annual
- March 25th, 2023
- Last Interim
- December 30th, 2023
- Incorporated
- March 20th, 2015
- Public Since
- May 25th, 2021
- No. of Employees
- 3,648
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 45,231,616
- Address
- 400-190 Attwell Drive, Toronto, M9W 6H8
- Web
- https://neighbourlypharmacy.ca/
- Phone
- +1 4163099102
- Auditors
- Ernst & Young LLP
Upcoming Events for NBLY
Neighbourly Pharmacy Inc Annual Shareholders Meeting
Q1 2025 Neighbourly Pharmacy Inc Earnings Release
Similar to NBLY
CareRx
Toronto Stock Exchange
Colabor
Toronto Stock Exchange
Empire
Toronto Stock Exchange
George Weston
Toronto Stock Exchange
Loblaw Companies
Toronto Stock Exchange
FAQ
What is the Neighbourly Pharmacy share price?
As of Today at 18:15 UTC, shares in Neighbourly Pharmacy are trading at CA$18.55. This share price information is delayed by 15 minutes.
How has the Neighbourly Pharmacy share price performed this year?
Shares in Neighbourly Pharmacy last closed at CA$18.55 and the price had moved by -19.84% over the past 365 days. In terms of relative price strength the Neighbourly Pharmacy share price has underperformed the Toronto Stock Exchange 300 Composite Index by -28.87% over the past year.
What are the analyst and broker recommendations for Neighbourly Pharmacy?
The overall consensus recommendation for Neighbourly Pharmacy is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Neighbourly Pharmacy dividend yield?
The Neighbourly Pharmacy dividend yield is 0.73% based on the trailing twelve month period.
Does Neighbourly Pharmacy pay a dividend?
Last year, Neighbourly Pharmacy paid a total dividend of CA$0.14, and it currently has a trailing dividend yield of 0.73%. We do not have any data on when Neighbourly Pharmacy is to next pay dividends.
When does Neighbourly Pharmacy next pay dividends?
We do not have data on when Neighbourly Pharmacy is to next pay dividends. The historic dividend yield on Neighbourly Pharmacy shares is currently 0.73%.
How do I buy Neighbourly Pharmacy shares?
To buy shares in Neighbourly Pharmacy you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Neighbourly Pharmacy?
As of the previous close price of CA$18.55, shares in Neighbourly Pharmacy had a market capitalisation of CA$839.05m.
Where are Neighbourly Pharmacy shares listed?
Here are the trading details for Neighbourly Pharmacy:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: NBLY
What kind of share is Neighbourly Pharmacy?
Based on an overall assessment of its quality, value and momentum Neighbourly Pharmacy is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Neighbourly Pharmacy share price forecast for 2024?
The analyst consensus target price for shares in Neighbourly Pharmacy is CA$19.29. That is 3.99% above the last closing price of CA$18.55.
Analysts covering Neighbourly Pharmacy currently have a consensus Earnings Per Share (EPS) forecast of CA$0.55 for the next financial year.
What is the trend in the Neighbourly Pharmacy share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Neighbourly Pharmacy. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +17.72%.
As of the last closing price of CA$18.55, shares in Neighbourly Pharmacy were trading +8.65% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Neighbourly Pharmacy PE Ratio?
The Neighbourly Pharmacy PE ratio based on its reported earnings over the past 12 months is 25.9. The shares last closed at CA$18.55.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Neighbourly Pharmacy?
We do not have data on Neighbourly Pharmacy's directors